William Scott Huneycutt, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2240 E Center St, Pocatello, ID 83201 Phone: 208-233-8344 Fax: 208-233-6983 |
Dr. Gregory S Harrison, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Suite 115, Pocatello, ID 83201 Phone: 208-239-2260 Fax: 208-239-3767 |
Jonathan T Morgan, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 333 N 18th Ave, Suite B4, Pocatello, ID 83201 Phone: 208-232-2233 Fax: 208-232-2299 |
News Archive
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by MSP Singapore Co. LLC in connection with VYTORIN® (ezetimibe/simvastatin), 10 mg/80 mg.
According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.
Family members are often called upon to make medical choices for patients who are unable to do so themselves. Researchers led by Alexia Torke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc., studied how physicians treating these patients interacted with surrogate decision-makers.
AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for NEXIUM(R) (esomeprazole magnesium) to seek approval for the short-term (up to 6 weeks) treatment of gastroesophageal reflux disease (GERD) in pediatric patients ages 0 to 1 year old.
› Verified 3 days ago